Heppt, Markus V. http://orcid.org/0000-0003-4603-1825
Steeb, Theresa
Schmitz, Lutz
Garbe, Claus
French, Lars E.
Leiter, Ulrike
Berking, Carola
Funding for this research was provided by:
Skin Cancer Council Germany (HF02-Z05-P02)
Article History
Received: 18 April 2019
Accepted: 3 September 2019
First Online: 11 October 2019
Ethics approval and consent to participate
: This study received an Institutional Review Board exemption from the Ethics Committee of the Medical Faculty of the LMU Munich on 2 April 2019 (approval number 19–098).
: Not applicable.
: CB has been a member of advisory boards for Almirall Hermal, Biofrontera, Galderma, ISDIN, and Leo Pharma. CB has received speaker’s honoraria from Almirall Hermal, Galderma, and Leo Pharma. CB has received funding for clinical research from Leo Pharma. LS has received speaker’s honoraria from Almirall Hermal, Galderma, Biofrontera, Mylan, and Beiersdorf. LS has been a member of advisory boards for Almirall Hermal. The remaining authors declare no conflicts of interests.